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We have performed this study to investigate the modulatory eﬀect of thymoquinone (TQ), the Nigella sativa active compound,
on erythrocyte lipid peroxidation and antioxidant status during 1,2-dimethylhydrazine- (DMH-) induced colon carcinogenesis
after initiation in male Wistar rats. Rats exposed to DMH showed an increase of malondialdehyde and conjugated diene levels,
and an augmentation of enzyme activities like catalase, glutathione peroxidase, and superoxide dismutase activities was also noted.
The TQ pretreatment restored the parameters cited above to near-normal values. However, the posttreatment shows an activity
similarasthatpresentedbyDMH.Therefore,ourinvestigationrevealedthatTQwasausefulcompoundpreventingDMH-induced
erythrocyte damages.
1.Introduction
Antioxidants such as glutathione, α-tocopherol, ascorbic
acid, superoxide dismutase, catalase, and peroxidase are
formed within cells to prevent the harmful eﬀects of re-
active oxygen species (ROS), such as superoxide anion
radical (O2
−•) hydroxyl radical (•OH), and peroxyl radical
(ROO•), which are continually generated in vivo both by
aerobic metabolism and exogenous sources such as UV
radiation, environmental pollution, and diet [1]. Oxidative
stress produced by free radicals has been associated with
the development of several diseases such as cardiovascular,
cancer,andneurodegenerativediseases[2].Colorectalcancer
is among the leading causes of cancer-related death and
one of the most commonly diagnosed cancers in western
developed countries [3]. 1,2-Dimethylhydrazine (DMH), a
potent colon carcinogen, undergoes oxidative metabolism
resulting in the production of electrophilic diazonium ion,
which is known to elicit oxidative stress in the RBCs [4].
In recent years, much eﬀort has been dedicated to a search
for natural or pharmacological preventive agents, which
would block or attenuate colorectal cancer process [5].
Epidemiological and experimental studies demonstrate the
importance of compounds derived from plants in reducing
the risk of colon cancer [6] and inhibit the development
and the multiplicity of tumors in experimental animals [7].
Nigella sativa L. is an annual herbaceous plant belonging to
the Ranunculaceae family, commonly used traditionally in
MiddleEasternfolkmedicineasanaturalremedyforvarious
diseasesforover2000years[8].Thymoquinone(TQ)wasthe
abundant Nigella sativa essential oil compound and known
to be the active principle responsible for many of the seed’s
antioxidant and anti-inﬂammatory eﬀects [3]. TQ has been
revealed to have promising antitumor eﬀects. It inhibited the
incidence of ﬁbrosarcoma tumors in mice induced with 20-
methylcholanthrene as well as forestomach tumors induced2 Oxidative Medicine and Cellular Longevity
with benzo(a)pyrene [9, 10]. The study of Badary [11]
has demonstrated that TQ attenuates ifosfamide-induced
Fanconi syndrome in rats, enhances its antitumor activity
in mices and increase, the antitumor eﬀects of ifosfamide.
Furthermore, TQ was shown to reduce cisplatin-induced
nephrotoxicity without disturbing its antitumor activity
[12]. Blood is the principal tissue in human body wherever
abnormal modiﬁcation in its parameters indicates the toxic
eﬀects of drug chemicals leading to diseases. In fact, changes
in RBCs have been detected in a number of human
pathologic conditions or after exposure to xenobiotics
displaying oxidative stress. Erythrocytes are permanently
in contact with potentially damaging levels of oxygen, but
their metabolic activity is capable of reversing this injury
under normal conditions, which are equipped by many
defense systems representing their antioxidant capacity [13].
Thisprotectivesystemincludessuperoxidedismutase(SOD),
catalase (CAT), reduced glutathione, glutathione peroxidase
(GPx), glutathione-S-transferase, and glutathione reductase
(GR) [14]. Oxidation of erythrocytes includes membrane
injury, methemoglobin formation, osmotic fragility, and the
destruction of the cell [15]. Further, oxidative stress in
red blood cells is an indicator of overall oxidative stress
besides RBC-related disorders. Thus, the present study
investigates the potential protective and curative eﬀect of
TQ in erythrocyte oxidative damage in postinitiation DMH
colon cancer in rats. So our funding assesses (1) the
hematological parameters count, (2) the levels of MDA, in
terms of thiobarbituric acid reactive substances (TBARS),
(3) the conjugated diene level, and (4) the activities of
antioxidant enzymes in the RBCs.
2.MaterialandMethods
2.1. Animal Experimental Design. Adult male Wistar rats
were bred in the animal care facility at the Faculty of
Pharmacy of Monastir (Tunisia). Rats were housed under
optimum conditions of temperature set at 22 ± 2◦Ca n d
light set at 12hrs light-dark cycle. Rats were kept in plastic
cages covered with sawdust and had unrestricted access to
a commercial rat diet (24% protein, 4.5% fat, and 4%
ﬁber) and water. All animal studies were conducted using
a protocol approved by the Institutional Animal Care and
Use Committee of the Faculty of Pharmacy of Monastir. The
toxicity of TQ in rats was determined prior to the DMH
animal experiment.
2.2. DMH Rat Experiment. One week after acclimatization,
the rats were randomly divided into 5 groups of ﬁve animals
each. Animals were treated once per week either with saline,
TQ, DMH, pretreatment (TQ + DMH) (10 weeks), or
posttreatment DMH (10 weeks) + TQ (10 weeks); DMH
(20mg/kgbw) was dissolved in isotonic saline and was
injected subcutaneously (s.c.) once per week on the dorsal
back. TQ (5mg/kgbw,) was injected (i.p.) once per week.
At the end of experimental period, the animals of diﬀerent
groups were sacriﬁced by cervical decapitation to avoid
stress.
2.3. Blood Samples Preparation. Blood samples were col-
lected into EDTA tubes. Some were immediately used for
the quantiﬁcation of hematological parameters. Others were
centrifuged at 2200×g for 15min. Plasma samples were
then removed and the sediments containing erythrocytes
were suspended in phosphate buﬀer saline solution (0.9%
NaCl in 0.01M phosphate buﬀer, pH 7.4) and centrifuged as
reportedbySinhaetal.[16].Thisprocesswasrepeatedtwice.
After removing cells’ debris by centrifugation at 3000×gf o r
15min, the hemolysate were obtained and stored at −80◦C
until biochemical analysis.
2.3.1. Hematological Study. Red blood cell counts (RBC),
white blood cells count (WBC), hemoglobin concentration
(Hb), hematocrit (Ht), mean corpuscular volume (MCV),
mean corpuscular hemoglobin (MCH), and mean corpus-
cular hemoglobin concentrations (MCHC) were quantiﬁed
in an automatic hematological assay analyzer (Beckman
Coulter, USA).
2.4. Biochemical Assays
2.4.1. Protein Quantiﬁcation. Protein content in the erythro-
cytes was determined using Protein-BioRad assay [17]a n d
bovine serum albumin as a standard.
2.4.2. Erythrocyte Lipid Peroxidation. Lipid peroxidation was
determined indirectly by measuring the production of MDA
in the erythrocytes extract following the method of Yagi,
[18]. Brieﬂy, 200μL of hemolysates were mixed with 150μL
of TBS (Tris 50mM and NaCl 150mM, pH 7.4) and 250μL
TCA-BHT (20% TCA and BHT 1%). The mixture was
vigorously vortexed and centrifuged at 1500g for 10min.
400μL of the supernatant were added with HCl 0.6N and
320μLTris-TBA(Tris26mMandTBA120mM),thecontent
was mixed and incubated 10min at 80◦C. The absorbance
was measured at 535nm. The optic density corresponding
to the complex formed with the TBA-MDA is proportional
to the concentration of MDA and to the lipid peroxide. The
concentration of μmol of MDA/mg of proteins is calculated
from the absorbance at 535nm using the molar extinction
coeﬃcient of MDA 1.56 × 105 M−1 cm−1. Another indicator
of the lipid peroxidation is the conjugated diene (CD) which
is measured as described by Esterbauer et al. [19]. The results
were expressed as μmol hydroperoxides/mg protein.
2.4.3. Determination of Antioxidant Enzyme Activities
(1) Catalase Activity. Catalase activity was measured in the
hemolysate at 240nm and 25◦C according to [20]. Brieﬂy,
20μL of the hemolysate were added in the quartz cuvette
containing 780μL phosphate buﬀer and 200μLo fH 202
0.5M. The activity of catalase was calculated using the molar
extinction coeﬃcient (0.04mM−1cm−1). CAT activity was
calculated in terms of μmole H2O2 consumed/min/mg of
protein (Figure 1).Oxidative Medicine and Cellular Longevity 3
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Figure 1: Erythrocyte CAT activity in adult rats of controls or
treated with DMH, TQ, and diﬀerent (TQ + DMH) treatments.
Values are means ± SE for ﬁve rats in each group. DMH, TQ, and
diﬀerent (TQ + DMH) groups versus control group:
∗P < 0.05;
∗∗P < 0.01;
∗∗∗P < 0.001, (TQ + DMH) groups versus DMH:
+P < 0.05; ++P < 0.01; +++P < 0.001. U: μmol of H2O2/min.
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Figure 2: Erythrocyte SOD activity in adult rats of controls or
treated with DMH, TQ, and diﬀerent (TQ + DMH) treatments.
Values are means ± SE for ﬁve rats in each group. DMH, TQ, and
diﬀerent (TQ + DMH) groups versus control group:
∗P < 0.05;
∗∗P < 0.01;
∗∗∗P < 0.001, (TQ + DMH) groups versus DMH:
+P < 0.05; ++P < 0.01; +++P < 0.001. U: Enzyme required for 50%
inhibition of NBT reduction.
(2) Superoxide Dismutase (SOD) Activity. Superoxide dis-
mutase (SOD) activity was estimated according to Beau-
champ and Fridovich [21]. The reaction mixture contained
50mM of hemolysate in potassium phosphate buﬀer (PH
7.8), 0.1mM EDTA, 13mM L-methionine, 2μM riboﬂavin,
and 75mM nitro blue tetrazolium (NBT). The developed
blue colour in the reaction was measured at 560nm. Units
of SOD activity were expressed as the amount of enzyme
required to inhibit the reduction of NBT by 50%, and the
activity was expressed as units/mg of protein (Figure 2).
(3) Glutathione Peroxidase (GPx) Activity. Glutathione per-
oxidase (GPx) activity was measured according to Flohe and
Gunzler [22]. The enzyme activity was expressed as nmol of
GSH oxidized/min/mg protein (Figure 3).
2.5. Statistical Analysis. The data were analyzed using the
Statistical Package for Social Sciences (SPSS) programme,
release 17.0 for Windows (SPSS, Chicago, IL, USA). In
each assay, the experimental data represent the mean of ﬁve
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Figure 3: Erythrocyte GPX activity in adult rats of controls or
treated with DMH, TQ, and diﬀerent (TQ + DMH) treatments.
Values are means ± SE for ﬁve rats in each group. DMH, TQ,
and diﬀerent (TQ + DMH) groups versus control group:
∗P <
0.05;
∗∗P < 0.01;
∗∗∗P < 0.001, (TQ + DMH) groups versus
DMH: +P < 0.05; ++P < 0.01; +++P < 0.001. U: μmol of GSH
oxidized/min.
independent assays ± standard deviations. The results were
analyzed using Tuckey’s test for comparison between the
diﬀerenttreatmentgroups.Thestatisticalsigniﬁcancewasset
at P<0.05.
3. Results
3.1. Hematological Parameters. The TQ pretreatment leads
to a signiﬁcant increase in WBC level with 114.57% and a
signiﬁcant decrease in PLT with 65.89% compared to control
andDMHgroups,respectively.TheTQposttreatmentcauses
compared to the control group a signiﬁcant decrease in
RBC number with 23.15% and a very signiﬁcant increase in
PLT and WBC levels with 394.89% and 192.3%, respectively
(Table 1).
3.2. Lipid Peroxidation in Erythrocytes. All the results from
various treatment groups were compared with their normal
control. However, results from diﬀerent (TQ + DMH)
groups were also compared with the data of DMH-treated
group. During this study, no sign of toxicity was observed
under DMH treatment at 20mg/kg. Rats exhibited normal
behavior in comparison to the control group. Our results
revealed a signiﬁcant increase of lipid peroxidation in the
erythrocytes of DMH, pretreatment, and posttreatment
groups with 35.62%, 32.65%, and 53.39%, respectively,
compared to control group (Table 2).
3.3. CD in Erythrocyte. Our result shows a signiﬁcant
increase in CD level only in the posttreatment with 40.15%
compared to control. However, the increase was 43.54%
compared to DMH group. The other groups show a non-
signiﬁcant diﬀerence compared to control or to DMH group
(Table 2).
3.4. Antioxidant Enzyme Activities. All the results from
various treatment groups were compared with their normal
control. However, results from pretreatment and posttreat-
ment groups were also compared with the data of DMH4 Oxidative Medicine and Cellular Longevity
Table 1: Hematologic parameters: red blood cell (RBC), hemoglobin (HGB), hematocrit (HCT), mean corpuscular volume (MCV), mean
corpuscular hemoglobin concentration (MCHC), mean corpuscular hemoglobin (MCH), platelet (PLT), and white blood cell (WBC) of
controls or treated rats with DMH, TQ, and diﬀerent (TQ + DMH) treatments.
Control TQ DMH Pretreatment Posttreatment
RBC (106mm−3)6 . 5 2 ± 0.46 5.934 ± 0.94 6.346 ± 1.1 6.73 ± 0.39 5.01 ±0.78
∗
HGB (g/dL) 11.48 ± 0.65 11.18 ± 1.5 10.74 ± 1.65 11.66 ± 0.40 10.88 ± 1.48
HCT (%) 32.58 ± 1.63 27.74 ± 4.36 30.4 ± 5.62 27.94 ± 1.38 34.16 ± 2.86
MCV (μm−3) 47.78 ± 1.88 47.48 ± 0.64 47.38 ± 0.68 47.48 ± 0.63 52.62 ±2.133
∗∗∗+++
MCHC (g/dL) 35.40 ± 0.21 38.1 ± 1.73 36.4 ± 0.92 34.48 ± 1.16 34.08 ± 1.5
MCH (pg) 16.88 ± 0.60 17.98 ± 0.88 17.16 ± 0.36 18.24 ± 1.36 17.9 ± 0.78
PLT (103 mm−3) 58.8 ± 10.96 134 ± 17.32 371.8 ±61.88
∗∗∗ 126.8 ±13.68+++ 291 ±77.81
∗∗∗
WBC (103 mm−3)2 . 4 7 ± 0.35 3.9 ± 0.86 5.88 ±0.82
∗∗∗ 5.3 ±0.63
∗∗ 7.22 ±0.98
∗∗∗
Values are means ± SE for ﬁve rats in each group.
DMH, TQ, and diﬀerent (TQ + DMH) groups versus control group: ∗P < 0.05, ∗∗P < 0.01, and ∗∗∗P < 0.001, TQ + DMH groups versus DMH: +P <
0.05, ++P < 0.01, and +++P < 0.001.
Table 2: Malondialdehyde (MDA) and conjugated dienes (CD) levels in erythrocytes of adult rat controls or treated with DMH, TQ, and
diﬀerent (TQ + DMH) treatments.
Control TQ DMH Pretreatment Posttreatment
CDa 1.27 ± 0.09 1.4 ± 0.25 1.29 ± 0.13 1.24 ± 0.04 1.78 ±0.194
∗∗∗+++
MDAb 13.11 ± 0.75 14.74 ± 1.81 20.59 ±0.54
∗∗∗ 17.39 ±1.025
∗∗∗++ 20.11 ±1.225
∗∗∗
Values are means ± SE for ﬁve rats in each group.
DMH, TQ, and diﬀerent (TQ + DMH) groups versus control group: ∗P < 0.05; ∗∗P < 0.01; ∗∗∗P < 0.001, TQ + DMH groups versus DMH:
+P < 0.05, ++P < 0.01, +++P < 0.001.
aμmol/mg of protein.
bμmol hydroperoxides/mg of protein.
treated group. The rats’ exposure to DMH resulted in
erythrocyte extensive oxidative damage as manifested by the
signiﬁcant increase (P<0.05) in CAT, SOD, and GPx
enzymes levels by 50.23%, 12.55%, and 352.9%, respectively,
compared to control group. In contrast, the pretreatment
decreases CAT, SOD, and GPx activities without reaching
normal values. The posttreatment shows a similar activity to
the DMH group in the diﬀerent enzymes.
4. Discussion
In this study, the inhibitory eﬀects of TQ on the hematolog-
ical parameters changes and oxidative stress enzymes were
observed in an experimental model of DMH-induced colon
carcinogenesis. It was clearly indicated that the pretreatment
with TQ in the presence of the procarcinogen DMH appre-
ciably attenuates the alterations in the erythrocytes levels
of lipid peroxidation and the overall antioxidant enzymatic
status.
The DMH was usually used for the induction of colorec-
tal carcinogenesis in rodents. It was metabolically activated
in the liver by a series of reactions [5, 23]. Blocking agents
are chemopreventive agents that prevent tumorigenesis by
blocking the carcinogen-DNA adduct formation [4]. Our
study showed that DMH induced oxidative damages in
erythrocytes, leading to hematotoxicity objectiﬁed by the
reduction of RBC counts and Hb concentration. This could
be the result of hematogenesis impairments by the inhibition
of RBC production from proerythroblast and by erythrocyte
destruction in hemopoietic organs. Several current medical
drugs are extracted from herbs, and about one-quarter of
prescription drugs contain at least one active compound
derived from plant material. Herbal therapies, including the
black seed (Nigella sativa) from which TQ is derived, have
shown antitumor promotion activities in rats or mice treated
withchemicalcarcinogens[3].Itsuppressesbenzo(a)pyrene-
(BP-) induced forestomach tumor formation [10], poten-
tiates the antitumor activity of cisplatin, and improves its
therapeutic index [24]. In this study we have observed that
TQ pretreatment leads to an increase of RBC counts and Hb
concentration to reach normal values.
The study conducted by Al-Amri and Bamosa had re-
ported no signiﬁcant systemic toxicities in adult patients
with solid tumors or hematological malignancies who
were treated with thymoquinone. Our results showed an
increase of MDA and CD level and an overexpression
of antioxidant enzyme activities. It clearly indicated that
DMH had the potency to cause oxidative damage in eryth-
rocytes. Antioxidant enzymes are considered to be the ﬁrst
line of cellular defense against oxidative damage. Among
them, superoxide dismutase (SOD), catalase (CAT), and
glutathione peroxidase (GPx) mutually function in the
eﬀects of oxidant molecules limitation on tissues and are
activeinthedefenseagainstoxidativecellinjurythankstothe
fact that they are free radical scavengers [14]. Consequently,
in the current study, it was suggested that the signiﬁcant
increase of the MDA and CD contents in the erythrocyte
proved the overexpression of antioxidant defense systemOxidative Medicine and Cellular Longevity 5
to limit the inﬂux of ROS generated by DMH exposure.
Enhanced MDA and CD associated with augmentation in
detoxifying (GPx) and antioxidant (CAT, SOD) enzymes
in the RBCs were observed in our study. These are the
characteristic ﬁndings in malignant transformation [25, 26].
It is evident from these results that, in DMH-treated rats, the
oxidant-antioxidant homeostasis was disturbed. Woo et al.
[27]havenotedthatthymoquinonecouldactasafreeradical
and superoxide radical scavenger, as well as preserving the
activity of various antioxidant enzymes such as catalase,
glutathione peroxidase, and glutathione-S-transferase. Our
study shows that the pretreatment with TQ causes the
depletion of antioxidant enzymes in RBCs to reach similar
value to the control group especially in CAT and GPx.
However, the posttreatment demonstrates a similar value to
the DMH group especially in SOD and GPx. These enzymes
work together to eliminate ROS where small deviations in
physiological concentrations may have a dramatic eﬀect on
the resistance of cellular lipids, proteins, and DNA to oxida-
tive damage. The antioxidant capability of thymoquinone
has been implicated in the prevention of chemical-induced
carcinogenesis. Numerous in vitro and in vivo studies have
provided ample evidence that thymoquinone could prevent
carcinogenesis and inhibit tumorigenesis through diﬀerent
molecular mechanisms [27]. The study of Ghali-Muhtasib
et al. [3] indicates that TQ inhibits tumor-cell invasion in
vitrowithIC50 of 40μM as well as ACF formation and tumor
development in DMH-induced mouse colon carcinogenesis
and in a xenograft model of human HCT-116 colon cancer
cells. Tumor growth inhibition by TQ in the DMH and
xenograft mouse models may be attributed to its potent anti-
inﬂammatory and antioxidant eﬀects.
5. Conclusion
The results from the present study show the beneﬁcial role
of the pretreatment with TQ in reducing some of the altered
biochemical variables suggestive of oxidative stress in RBCs
in DMH colon cancer. More studies have to be performed
before thymoquinone can be developed into a drug for the
potential treatment of various carcinomas and inﬂammatory
disorders. Thus, clinical trials could be made with this agent
withpatientstoenrichthymoquinoneeﬀectsdatainhumans
and to enhance its beneﬁcial eﬀect.
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